Table 8.
Molecular genetic analysis of MMR mutation negative tumours [16].
__ | MMR Mutation Negative Tumours | % |
---|---|---|
MSS | 52 out of 52 | 100% |
APC mutation | 10 out of 52 | 19.2% |
Nuclear beta-catenin | 16 out of 44 | 36% |
Membranous beta-catenin | 28 out of 44 | 63% |
APC mutation | 9 out of 16 (of tumours with nuclear beta-catenin) |
56% (of tumours with nuclear beta-catenin) |